0

NCX 4016

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP175033360
CAS175033-36-0
Structure
MDL NumberMFCD01939436
Molecular Weight331.28
Description≥98% (HPLC)
SolubilityDMSO: 25 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

NCX-4016 (NO-aspirin) Inhibits Lipopolysaccharide-Induced Tissue Factor Expression in Vivo: Role of Nitric Oxide

Stefano Fiorucci, Andrea Mencarelli, Alessandra Meneguzzi, Alessandro Lechi, Antonio Morelli, Piero del Soldato, Pietro Minuz

Circulation. 2002 Dec 10;106(24):3120-5.

PMID: 12473561

1

NCX-4016 NicOx

Mario Di Napoli, Francesca Papa

Curr Opin Investig Drugs. 2003 Sep;4(9):1126-39.

PMID: 14582459

1

NCX-4016 NicOx SA

T W Huizinga

IDrugs. 1998 Jun;1(2):228-31.

PMID: 18465536

1

NCX-4016, a Nitro-Derivative of Aspirin, Inhibits EGFR and STAT3 Signaling and Modulates Bcl-2 Proteins in Cisplatin-Resistant Human Ovarian Cancer Cells and Xenografts

Karuppaiyah Selvendiran, Anna Bratasz, Liyue Tong, Louis J Ignarro, Periannan Kuppusamy

Cell Cycle. 2008 Jan 1;7(1):81-8.

PMID: 18196976

1

Nitroaspirin (NCX-4016), an NO Donor, Is Antiangiogenic Through Induction of Loss of Redox-Dependent Viability and Cytoskeletal Reorganization in Endothelial Cells

Narasimham L Parinandi, Ashish Sharma, Timothy D Eubank, Bruce F Kaufman, Vijay Kumar Kutala, Clay B Marsh, Louis J Ignarro, Periannan Kuppusamy

Antioxid Redox Signal. 2007 Nov;9(11):1837-49.

PMID: 17760507

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode